Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. reports news around its U.S. healthcare business, combining Humana insurance services with CenterWell healthcare services. Company updates commonly address Medicare Advantage and other health plan membership, Insurance segment benefit ratios, GAAP and adjusted earnings, full-year guidance, and capital returns through quarterly dividends.
News also covers CenterWell's senior-focused primary care, home health, pharmacy, hospice and retail pharmacy activities; prescription access and home delivery partnerships; healthcare research tied to medication adherence and chronic disease care; palliative care arrangements; health data interoperability; and board refreshment or other governance actions.
Humana Inc. (NYSE: HUM) has received notification from the Louisiana Department of Health to award a contract for providing Medicaid coverage in Louisiana. The Medicaid division, Humana Healthy Horizons, plans to commence service later this year, contingent on completing the protest period. The initiative aims to enhance health outcomes for 1.6 million Medicaid beneficiaries in Louisiana through a holistic care approach. This selection underscores Humana's commitment to improving community health and supporting urgent needs through programs addressing social determinants of health.
Humana Inc. (NYSE: HUM) announced that CEO Bruce D. Broussard will present at the 11th Annual SVB Leerink Global Healthcare Conference on February 18, 2022, at 11:20 a.m. ET. Interested investors can access a live audio webcast on Humana’s Investor Relations page at humana.com. The company emphasizes its commitment to integrated healthcare, aiming to improve health and reduce costs for its members through various services, including in-home care and data analytics.
Summary not available.
Humana Specialty Pharmacy announced the addition of two oncology therapies: TAGRISSO® (osimertinib) for EGFRm non-small cell lung cancer and LENVIMA® (lenvatinib) for various cancers. These drugs will be delivered directly to patients, supported by Humana's Oncology Center of Excellence, which offers expert guidance on treatment. Humana is dedicated to enhancing patient experiences and health outcomes while managing chronic and complex illnesses through personalized services.
Humana reported a 4Q21 loss per common share of $0.11 on a GAAP basis, while adjusted EPS stood at $1.24. For FY 2021, GAAP EPS was $22.67, down from $25.31 in FY 2020. The company anticipates FY 2022 GAAP EPS of at least $23.08 and adjusted EPS of at least $24.00, considering a $1.00 negative COVID-19 impact. Humana plans to create $1 billion in value through cost savings and productivity initiatives, focusing on its Medicare Advantage business and healthcare services expansion.
Humana Inc. (NYSE: HUM) has announced winners of its 2021 Go365 National Step Challenge, involving over 33,000 participants from various companies. Participants collectively logged 7.2 billion steps, leading to a donation of meals to local food banks, totaling an equivalent of one million meals. The challenge promotes health and community support, with winners from different divisions receiving donations in their names. The initiative has provided 4 million meals to Feeding America since its inception in 2018, addressing food insecurity while encouraging healthier lifestyles.
Humana Inc. is set to expand its CenterWell Senior Primary Care network by opening 26 new centers in 2022, enhancing access for underserved seniors across the Dallas-Ft. Worth, Phoenix, Louisville, Nashville, and Charlotte markets. This expansion will mark CenterWell's entry into Arizona, Kentucky, and Tennessee. With approximately 200 existing centers across nine states, the organization aims to increase this number to between 240-260 by year-end, improving personalized healthcare for 300,000 Medicare patients.
Humana Inc. (NYSE: HUM) has appointed Dr. Andrew Agwunobi, a seasoned health care executive, as President of its Home Solutions business, effective February 21. Dr. Agwunobi previously served as interim President of the University of Connecticut and CEO of UConn Health. He has extensive experience in health care operations, including leadership roles in various health systems. His expertise in home health care aligns with Humana's vision to enhance at-home care services, particularly in the wake of increased demand during the COVID pandemic.
Humana Inc. (NYSE: HUM) will announce its fourth quarter 2021 financial results on February 2, 2022, at 6:30 a.m. Eastern time. A conference call to discuss the results and 2022 earnings guidance will occur at 9:00 a.m. Eastern time on the same day. Telephone participants must register in advance to receive call details. A webcast will also be available on Humana’s Investor Relations page. The earnings release is expected to include non-GAAP financial measures with detailed reconciliations provided.
Humana and Vancouver Clinic have partnered to enhance access to patient-centered primary care in Gresham, Oregon, through the new Enliven facility. This initiative is part of Humana's expanding Medicare Advantage network, accepting all HMO and PPO plans in the state. Enliven aims to improve healthcare access with integrated care teams addressing the complex health needs of older adults. As of September 30, 2021, Humana serves over 3.1 million Medicare Advantage members through a comprehensive value-based care network.